Glaukos Corp. (GKOS)
122.64
-3.70
(-2.93%)
USD |
NYSE |
Jun 10, 16:00
122.64
0.00 (0.00%)
After-Hours: 20:00
Glaukos Enterprise Value : 7.199B for June 9, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 09, 2026 | 7.199B |
| June 08, 2026 | 6.944B |
| June 05, 2026 | 7.121B |
| June 04, 2026 | 6.928B |
| June 03, 2026 | 6.458B |
| June 02, 2026 | 6.291B |
| June 01, 2026 | 5.844B |
| May 29, 2026 | 5.858B |
| May 28, 2026 | 6.043B |
| May 27, 2026 | 6.280B |
| May 26, 2026 | 6.579B |
| May 22, 2026 | 6.888B |
| May 21, 2026 | 7.992B |
| May 20, 2026 | 8.273B |
| May 19, 2026 | 8.043B |
| May 18, 2026 | 8.177B |
| May 15, 2026 | 8.285B |
| May 14, 2026 | 8.175B |
| May 13, 2026 | 7.890B |
| May 12, 2026 | 7.835B |
| May 11, 2026 | 7.777B |
| May 08, 2026 | 7.669B |
| May 07, 2026 | 7.706B |
| May 06, 2026 | 7.771B |
| May 05, 2026 | 7.663B |
| Date | Value |
|---|---|
| May 04, 2026 | 7.805B |
| May 01, 2026 | 8.062B |
| April 30, 2026 | 8.265B |
| April 29, 2026 | 6.696B |
| April 28, 2026 | 6.853B |
| April 27, 2026 | 6.971B |
| April 24, 2026 | 6.936B |
| April 23, 2026 | 6.901B |
| April 22, 2026 | 6.946B |
| April 21, 2026 | 6.973B |
| April 20, 2026 | 7.116B |
| April 17, 2026 | 7.130B |
| April 16, 2026 | 6.944B |
| April 15, 2026 | 6.908B |
| April 14, 2026 | 6.880B |
| April 13, 2026 | 6.820B |
| April 10, 2026 | 6.639B |
| April 09, 2026 | 6.817B |
| April 08, 2026 | 6.769B |
| April 07, 2026 | 6.561B |
| April 06, 2026 | 6.656B |
| April 02, 2026 | 6.426B |
| April 01, 2026 | 6.400B |
| March 31, 2026 | 6.109B |
| March 30, 2026 | 5.927B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Globus Medical, Inc. | 10.68B |
| Insulet Corp. | 11.52B |
| Abbott Laboratories | 186.33B |
| AngioDynamics, Inc. | 487.94M |
| Alphatec Holdings, Inc. | 1.742B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -19.78M |
| Revenue (Quarterly) | 150.57M |
| Total Expenses (Quarterly) | 170.35M |
| EPS Diluted (Quarterly) | -0.341 |
| Gross Profit Margin (Quarterly) | 77.86% |
| Profit Margin (Quarterly) | -13.14% |
| Earnings Yield | -2.68% |
| Normalized Earnings Yield | -1.564 |